The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study.
Jiangtao YuZiwen XuAnyang LiJindi ZhangYi WangHongqin ZhaoHaiyan ZhuPublished in: Drug design, development and therapy (2019)
Apatinib seems active in heavily-pretreated metastatic or recurrent cervical cancer. The adverse effects were moderate but manageable.